FDA Making A Generic Case For Continuous Manufacturing
The industry that makes the vast majority of drugs has yet to embrace the new production approach, but FDA hopes that platform standardization will make it more compelling.
The industry that makes the vast majority of drugs has yet to embrace the new production approach, but FDA hopes that platform standardization will make it more compelling.